Crispr Therapeutics Price Target Announced at $160.00/Share by JMP Securities
Crispr Therapeutics Price Target Announced at $160.00/Share by JMP Securities
DJ Crispr Therapeutics Initiated at Outperform by JMP Securities
Ratings actions from Benzinga: https://www.benzinga.com/stock/CRSP/ratings
(END) Dow Jones Newswires
March 04, 2021 08:16 ET (13:16 GMT)
DJ Crispr Therapeutics Price Target Announced at $160.00/Share by JMP Securities
Ratings actions from Benzinga: https://www.benzinga.com/stock/CRSP/ratings
(END) Dow Jones Newswires
March 04, 2021 08:16 ET (13:16 GMT)
DJ Crispr Therapeutics Initiated at Outperform by JMP Securities
由JMP证券发起的DJ Crispr治疗公司强于大盘
Ratings actions from Benzinga: https://www.benzinga.com/stock/CRSP/ratings
来自本辛加的评级行动:https://www.benzinga.com/stock/CRSP/ratings
(END) Dow Jones Newswires
(完)道琼通讯社
March 04, 2021 08:16 ET (13:16 GMT)
2021年3月4日08:16美国东部时间(格林尼治标准时间13:16)
DJ Crispr Therapeutics Price Target Announced at $160.00/Share by JMP Securities
JMP证券宣布DJ Crispr治疗公司每股160.00美元的目标价
Ratings actions from Benzinga: https://www.benzinga.com/stock/CRSP/ratings
来自本辛加的评级行动:https://www.benzinga.com/stock/CRSP/ratings
(END) Dow Jones Newswires
(完)道琼通讯社
March 04, 2021 08:16 ET (13:16 GMT)
2021年3月4日08:16美国东部时间(格林尼治标准时间13:16)
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧